An early-stage lung cancer diagnosis: What comes next? Join Dr. Sarah Waliany at Lung Cancer OncTalk 2026 to learn about key testing and treatment options. 📅 Dec. 8 & 10 | Free & virtual Register: give.cancergrace.org/event/2… #LungCancer

Meet Lung Cancer OncTalk 2026 chair Dr. Alissa Cooper! Join two evenings of lung cancer education and live Q&A. 📅 Dec. 8 & 10 ⏰ 7:30–8:45 PM ET 💻 Attend one or both virtual sessions! Register: give.cancergrace.org/event/2… #LungCancer #CancerGRACE

Join Lung Cancer OncTalk 2026, led by Dr. Alissa Cooper! Hear about current and emerging treatments and ask experts your questions live. 📅 Session 1: Tuesday, December 8, 2026 📅 Session 2: Thursday, December 10, 2026 ⏰ Both sessions: 4:30–5:45 PM PT | 7:30–8:45 PM ET Attend one or both sessions! Register: give.cancergrace.org/event/2… #LungCancer #LiveWebinar

What is MRD, and what can it tell you about your blood cancer treatment? 🔎 Our patient-friendly article explains measurable residual disease (MRD), how doctors test for it, and what MRD-positive and MRD-negative results may mean. Explore the basics and find helpful questions to ask your healthcare team. 📖 Read the article: cancergrace.org/post/what-me… #BloodCancer #MRD #PatientEducation #CancerGRACE

Does every lung nodule mean lung cancer—and when does it need surgery? Following Pope Leo XIV’s lung cancer diagnosis, learn when doctors monitor a lung nodule, recommend a biopsy, or consider surgery. We explain CT screening, nodule size and growth, and follow-up guidelines. Follow Larry, a fictional 68-year-old patient, inside illustrated lung tissue, an embedded nodule, and its cells. Learn the difference between screening and nodule follow-up, why biopsy is not always the first step, and which changes can prompt specialist evaluation. The incidental-nodule size guide applies to a single solid nodule in adults 35 or older, outside screening, without known cancer or weakened immunity. Multiple nodules and ground-glass/part-solid nodules follow different pathways. U.S. screening recommendations differ: USPSTF includes a 15-year quitting cutoff; ACS does not. EPISODE PAGE & LEARNING RESOURCES youtu.be/9vwuA_EbCxk?si=cdSS…

💙 Thank you for joining Blood Cancers OncTalk 2026! To every patient, caregiver, and community member who joined us: thank you for your time, thoughtful questions, and participation. A heartfelt thank-you to our chair, Dr. Yumeng “Julia” Zhang, and our speakers, Dr. Blue, Dr. Ashwath Gurumurthi, Dr. Supreet Kaur, and Dr. Shivani Handa, for sharing their expertise and making complex topics more accessible to patients and families. We’re also deeply grateful to our sponsors—Takeda Oncology, Lilly Oncology, Bristol Myers Squibb, and Janssen—for helping make this free educational event possible. Together, we’re helping more people access trusted cancer education. Thank you for being part of the GRACE community! 💙 #BloodCancer #CancerEducation #GRACE #OncTalk

🔴 Another audience question in our live Q&A! In a patient in their #30s, how do doctors distinguish clonal hematopoiesis of indeterminate potential (CHIP) from polycythemia vera (PV) when there is a JAK2 mutation, persistently high platelets, elevated red blood counts below PV diagnostic thresholds, and a lower-end erythropoietin (EPO) level? Our panel is discussing this diagnostic question at Blood Cancers OncTalk 2026. 💬 Join us now to hear more! It’s free: give.cancergrace.org/event/b… #MPNs #BloodCancer #GRACE #OncTalk

🔴 Our second panel’s live Q&A is underway at Blood Cancers OncTalk 2026! Our experts are answering your questions about MPNs: ▪️ What determines someone’s risk of complications like blood clots, and how does that guide treatment? ▪️ What changes in blood counts, symptoms, or test results could signal that an MPN is progressing? 💬 Join us now to hear the discussion and bring your questions! It’s free: give.cancergrace.org/event/b… #MPNs #BloodCancer #GRACE #OncTalk

🔴 How do we treat #myelofibrosis? Dr. Shivani Handa is discussing treatment options for myelofibrosis as part of her presentation on MPNs at Blood Cancers OncTalk 2026. 💬 Join us now to hear more about it! It’s free: give.cancergrace.org/event/b… #Myelofibrosis #MPNs #BloodCancer #GRACE #OncTalk

🔴 Happening now: Complications in MPNs, #Thrombosis Dr. Shivani Handa is discussing blood clot risks associated with myeloproliferative neoplasms (MPNs) at Blood Cancers OncTalk 2026. 💬 Join us now to hear more about it! It’s free: give.cancergrace.org/event/b… #MPNs #BloodCancer #GRACE #OncTalk

🔴 Taking the virtual stage: Dr. Shivani Handa! Now presenting “Myeloproliferative Neoplasms (MPNs) in 2026” at Blood Cancers OncTalk. Learn about MPN symptoms and blood clot risks, who may need treatment, available options, and newer treatment developments. 💬 Join us now to hear more about it! It’s free: give.cancergrace.org/event/b… #MPNs #BloodCancer #GRACE #OncTalk

🔴 Now presenting: Dr. Supreet Kaur! How can your immune system help fight lymphoma? Dr. Kaur is discussing CAR T-cell therapy and bispecific antibodies for aggressive B-cell lymphoma at Blood Cancers OncTalk 2026. Together, we’ll explore: ▪️ Who these treatments are for ▪️ What to expect before, during, and after treatment ▪️ How side effects are monitored and managed 💬 Join us now to hear more about it! It’s free: give.cancergrace.org/event/b… #Lymphoma #CARTCellTherapy #BloodCancer #GRACE #OncTalk

🔴 Our live Q&A is underway at Blood Cancers OncTalk 2026! First up: a question about #lenalidomide’s safety and concerns about reports patients may have heard. Our experts are discussing how to understand treatment benefits and risks. 💬 Join us now to hear the discussion and bring your questions! It’s free: give.cancergrace.org/event/b… #BloodCancer #MultipleMyeloma #GRACE #OncTalk

🔴 Happening now at Blood Cancers OncTalk 2026! How do doctors distinguish cancer cells from normal cells? Dr. Ashwath Gurumurthi is exploring this question, including a look at chromosome changes in leukemia, as part of his presentation on measurable residual disease (MRD). Join us now to hear more about it! It’s free: give.cancergrace.org/event/b… #BloodCancer #MRD #Leukemia #GRACE #OncTalk

🔴 Now presenting: Dr. Ashwath Gurumurthi! What is measurable residual disease (MRD)? It refers to tiny amounts of cancer that may remain during or after treatment, even when standard tests no longer detect it. At Blood Cancers OncTalk 2026, Dr. Gurumurthi is explaining how MRD testing finds and measures these cells—and why they matter when understanding the risk of relapse. 💬 Join us now to hear more about it! It’s free: give.cancergrace.org/event/b… #MRD #BloodCancer #CancerEducation #GRACE #OncTalk

🔴 What is a bispecific antibody? These treatments act as “molecular matchmakers,” bringing a T-cell and a myeloma cell together to help the immune system recognize and attack the cancer. They’re ready to use and given regularly by injection or IV. Dr. Blue is explaining more at Blood Cancers OncTalk 2026. Join us now to hear more about it! 👉 Join for free: give.cancergrace.org/event/b… #MultipleMyeloma #BloodCancer #GRACE #OncTalk

"#MultpleMyeloma is one of those cancers that isn't quite in the curable range yet but we are very close and we are working on that" Dr. Blue. Dr. Blue is discussing “Multiple Myeloma: From Diagnosis to Relapse — Myeloma 101” at Blood Cancers OncTalk 2026. Join us now to hear more about it! It’s free: give.cancergrace.org/event/b… #MultipleMyeloma #BloodCancer #GRACE #OncTalk

🔴 Now presenting: Dr. Blue! Join us LIVE at Blood Cancers OncTalk 2026 for “Multiple Myeloma: From Diagnosis to Relapse — Myeloma 101.” Learn the basics of multiple myeloma and how treatment approaches evolve from diagnosis through relapse. 👉 Join us for free: give.cancergrace.org/event/b… #MultipleMyeloma #BloodCancer #GRACE #OncTalk

🔴 We’re LIVE! Blood Cancers OncTalk 2026 is happening now! Join Dr. Yumeng “Julia” Zhang and leading oncologists for updates on blood cancer treatments, patient-centered discussions, and a live Q&A. 💬 Bring your questions and join us. It’s free! 👉 Join now:give.cancergrace.org/event/b… #BloodCancer #CancerEducation #GRACE #OncTalk